APA (7th ed.) Citation

V, R., B, B., J, L., MO, M., M, D., J, S., . . . J, J. (2024). Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies. The journal of prevention of Alzheimer's disease, 11(5), 1241. https://doi.org/10.14283/jpad.2024.146

Chicago Style (17th ed.) Citation

V, Ramakrishnan, et al. "Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies." The Journal of Prevention of Alzheimer's Disease 11, no. 5 (2024): 1241. https://doi.org/10.14283/jpad.2024.146.

MLA (9th ed.) Citation

V, Ramakrishnan, et al. "Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies." The Journal of Prevention of Alzheimer's Disease, vol. 11, no. 5, 2024, p. 1241, https://doi.org/10.14283/jpad.2024.146.